Hormone Replacement Therapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028

Published on : Oct-2018 | List of Tables : 33 | List of Figures : 126 | No. of Pages : 170 | Report Code : FACT2224MR |

Key Findings

Top Five Companies Account for 35% Share of the Overall Hormone Replacement Therapy Market

The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players. Top five companies involved in the hormone replacement therapy formulations account for a significant share of the overall hormone replacement therapy market. Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and Bayer AG collectively – collectively account for 35 percent revenue share of the hormone replacement therapy market from on the global front.

Tier 1 hormone replacement therapy companies are focused on carrying out clinical trials for new product development (NPD). Moreover, these companies are adopting vertical, horizontal and backward integration in a bid to achieve rapid expansion and pace in technological development.

In addition, tier 1 hormone replacement therapy companies are forming alliances to co-develop and commercialize hormone replacement therapy drugs. For instance, Pfizer Inc., and Merck KGaA have formed a strategic alliance to develop avelumab (BAVENCIO) to manage hypothyroidism and other thyroid disorders.

hormone replacement therapy market 0

Agreement between FDA and NASEM to Impact Hormone Replacement Therapy Market Growth

Food and Drug Administration (FDA) has signed an agreement with NASEM (National Academies of Science, Engineering & Medicine) and is carrying out expanded agreements with University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation. Main focus behind this initiative was to conduct research and inform consumers regarding compounded drugs.

NASEM is examining the utility of treating individuals with compounded BHRT (Bioidentical Hormone Replacement Therapy) products. Compounded Bioidentical hormone replacement therapy products such as testosterone and progesterone are used instead of FDA approved hormone replacement therapy drugs as BHRT drugs are considered more safe and natural for patients. This factor is likely to impact the clinical trials of new hormone replacement therapy products in turn challenging the growth of hormone replacement therapy market.

Use of Low Cost Generic Versions of Hormone Replacement Therapy Drugs – An Upcoming Trend

Affordability has always remained a major challenge for any pharmaceutical drug or formulation. Moreover, insufficient healthcare reimbursements have resulted in individuals opting for cheaper drugs with unclear drug effectiveness. This prompted manufactures of hormone replacement therapy drugs to produce generic versions of the formulations in a bid to bridge the gap between purchasing power of people and hormone replacement therapy drug pricing. Companies developing generic hormone replacement therapy drugs are also acquiring FDA approvals, which is direct inference apropos to drug effectiveness. For instance, Teva pharmaceuticals has introduced generic version of Estrace cream and estradiol vaginal cream in 2018. The trend is expected to auger well for the overall growth of the hormone replacement therapy market.

Rising Prevalence of Osteoporosis to Influence Hormone Replacement Therapy Demand

Growing life expectancy is closely associated with degeneration that further translates into osteoporotic fractures. In addition, this condition further results in an increase in gap between spine bones during menopause with diminishing estrogen levels. According to the International Osteoporosis Foundation, osteoporosis causes over 8.9 million fractures annually on the global front and is likely to grow in the coming years. Rising prevalence of osteoporosis among women is expected to trigger the demand for hormone replacement therapy.

Hormone Replacement Therapy Associated with Reduced Dementia – Key Growth Propellant  

Hormone replacement therapy can protect memory which is required to carry out short-term cognitive tasks after menopausal stress. Estrogen-only hormone replacement therapy can facilitate lower stress levels without impacting memory. In addition, hormone replacement therapy also reduces possibilities of both vascular dementia and Alzheimer’s disease.  

Combination Hormone Replacement Therapy Associated with Cancer – Key Growth Deterrent

Use of hormone replacement therapy can lead to cancerous cell development. The use of combination hormone replacement therapy (combination of progesterone and estrogen) can increase the risk of breast cancer by 75 percent even if used for a short timeframe. According to the U.S Women’s Health Initiative, the use of combination hormone replacement therapy comes with the risk of development of several cancers including ovarian and uterus cancers. This aspect is expected to confine the growth in adoption of hormone replacement therapy in the forthcoming years. Other hormone replacement therapy related disorders such as stroke, cardiac disorders and blood clots are further expected to negatively impact the growth of the hormone replacement therapy market.

To know about other key influencing factors, request sample report on hormone replacement therapy market.

Competitive Landscape

The report on hormone replacement therapy market offers intelligence on key participants in the hormone replacement therapy market. The key companies involved in the formulation of hormone replacement therapy products are thoroughly assessed and profiled in the report. Various facets of competition including SWOT analysis, product portfolio analysis, drug developments and innovations, strategies and key financials are covered. Key companies profiled in the report include Novartis AG, Novo Nordisk A/S, Teva Pharmaceuticals, Mylan N.V and Pfizer Inc.

hormone replacement therapy market 1

Major companies in the hormone replacement therapy market are concentrating on expanding their current product portfolio. New hormone replacement therapy formulations being the core focus, companies are carrying out trials and gain FDA approvals. For instance, Novartis AG’s research and development department delivered 6 critical FDA breakthrough therapy designations and 16 submissions in 2017. In May 2017, Novartis AG announced U.S. FDA’s approval for its hormone replacement therapy tablets for hormone receptor positive and metastatic breast cancer treatment in postmenopausal women.

hormone replacement therapy market 2

In February 2018, Novo Nordisk A/S concluded main phase of REAL 1 – the pivotal phase 3 trial along with somapacitan, a long-acting growth hormone to treat adults with growth hormone deficiency.

Teva Pharmaceuticals Industries Ltd. introduced Vagifem in 2017 for the treatment of atrophic vaginitis. In January 2018, the company launched Estrace cream to treat moderate and severe symptoms of vaginal and vulgar atrophy occurring due to menopause. Likewise, Mylan N.V expanded its US portfolio in the women’s healthcare range with U.S. FDA approval for Estradiol Vaginal Cream to treat vaginal atrophy.

Private equity firms are focused on acquiring emerging participants that are involved in drug delivery systems in the hormone replacement therapy space. For instance, Riverside Company has acquired DoseLogix in a bid to provide innovative dosing dispensers for ensuring accurate dosing medications of hormone replacement therapy and other conditions.

Click to know more on competitive scenario in the hormone replacement therapy market to understand key strategies of market participants

Definition

Hormone replacement therapy, also referred to as menopausal hormone therapy, is used to treat various symptoms related to menopause among women. Hormone replacement therapy replaces hormones that are low in level as women near menopause. There are various types of hormone replacement therapy such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy.

About the Report

The report on hormone replacement therapy market provides incisive insights on all aspects influencing growth in demand for hormone replacement therapy worldwide. The report provides a thorough analysis on demand of hormone replacement therapy across key regions in the globe along with sales of various hormone replacement therapy products.

Key drivers, challenges, trends and opportunities shaping the growth of the hormone replacement therapy market are also covered in the hormone replacement therapy market report. The hormone replacement therapy market report provides historical data assessment on use of hormone replacement therapy, current hormone replacement therapy scenario and future demand of hormone replacement therapy. The forecast projections provided cover a timeline of 10 years (2018-2028).

Market Structure

The hormone replacement therapy market is segmented in detail to cover every angle of the hormone replacement therapy space. The hormone replacement therapy market has been segmented on the basis of product type, by dosage form, by indication, by distribution channel and by region.

Various hormone replacement therapy products such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy is covered. By dosage form, hormone replacement therapy market is segmented into tablets, patches, injections, implants and creams. By indications, hormone replacement therapy market is categorized into menopause, osteoporosis, thyroid and growth hormone deficiency. By distribution channel, it is segmented by hospital pharmacies, clinics, retail pharmacies and online pharmacies.

The hormone replacement therapy market is assessed across key regions such as North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Middle East and Africa (MEA) and Japan.

Additional Questions Answered

Apart from key findings mentioned above, the hormone replacement therapy market report also answers additional questions such as:

  • Which is the most attractive regional market for hormone replacement therapy?
  • Which dosage form is largely preferred for using hormone replacement therapy worldwide?
  • Due to which indication is the hormone replacement therapy market is witnessing a significant upswing in demand?
  • Which country in the APEJ region accounts for a higher market share in the APEJ hormone replacement therapy?
  • Which is the most lucrative hormone replacement therapy distribution channel?

Research Methodology

The hormone replacement therapy market is drafted using a unique research methodology comprising of a combination of secondary and primary research methodologies. The data gleaned from primary and secondary research is assessed along with information from external sources. All the statistics are compiled using triangulation method to gain highly accurate projections on hormone replacement therapy market.

Request methodology on hormone replacement therapy market report.

The “hormone replacement therapy market forecast, trend analysis and competition tracking – global market insights, 2018-2028” report is an exclusive study revealing several facets of hormone replacement therapy market. The hormone replacement therapy market report includes forecast projections for a period of 10 years, form 2018 to 2028. The hormone replacement therapy market study also includes various aspects impacting the demand and sales of various hormone replacement therapy products worldwide along with a year-on-year growth assessment of hormone replacement therapy. Historical data on hormone replacement therapy adoption, current hormone replacement therapy scenario and future projections on hormone replacement therapy market are provided in the hormone replacement therapy market report.

Chapter 1 – Executive Summary

The executive summary of hormone replacement therapy market report provides over view of the hormone replacement therapy market along with critical market analysis, analyst recommendations, and wheel of fortune revealing opportunity assessment.

Chapter 2 – Market Introduction

This chapter in the hormone replacement therapy market report covers definition of the hormone replacement therapy market. It also includes detailed segmentation of hormone replacement therapy market along with scope of research.

Chapter 3 – Market Dynamics

This vast chapter covers analysis on various aspects impacting the demand for hormone replacement therapy. Various drivers, trends, restraints or challenges and opportunities in the hormone replacement therapy market influencing sales of hormone replacement therapy drugs or formulations worldwide are included in this chapter.

Chapter 4 – Associate Industry Dynamics

This chapter in the hormone replacement therapy market report mainly focuses on key regulations circling the hormone replacement therapy space. Political, economic, social, technological and environmental (PESTLE) analysis is also provided in this chapter. It also covers average selling prices of hormone replacement therapy across every country.

Chapter 5 – Key Inclusions

This chapter includes patient journey in hormone replacement therapy (HRT), treatment preference of physicians and top brands prescribed across every country.

Chapter 6 – Hormone Replacement Therapy Market Analysis

This chapter provides the overall hormone replacement therapy market outlook. It includes overall market valuation and forecast analysis along with regional demand assessment.

Chapter 7 – Hormone Replacement Therapy Market by Therapy Type

This chapter in the hormone replacement therapy market report includes a year-on-year assessment on various therapy types in the hormone replacement therapy market. Analysis on various types such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy is provided in the chapter.

Chapter 8 – Hormone Replacement Therapy Market by Dosage Form

Assessment on various dosage forms facilitating administration of hormone replacement therapy drugs is covered here. The chapter includes analysis on demand projections of various hormone replacement therapy dosage forms including tablets, patches, implants, creams and injection.

Chapter 9 – Hormone Replacement Therapy Market by Disease Indications

This chapter in the hormone replacement therapy market report includes thorough analysis on disease indications of hormone replacement therapy such as menopause, osteoporosis, thyroid and growth hormone deficiency.

hormone replacement therapy market 3

Chapter 10 – Hormone Replacement Therapy Market by Distribution Channel

This chapter in the hormone replacement therapy market report includes intelligence on the most attractive distribution channel for hormone replacement therapy. Market attractiveness of each channel including hospital pharmacies, retail pharmacies, clinics and online pharmacies is provided here.

Chapter 11 – North America Hormone Replacement Therapy Market

This chapter covers a country wise assessment on use of hormone replacement therapy in North America region. Key countries of United States and Canada are covered. Hormone replacement therapy market segmental outlook across these countries is provided here.

Chapter 12 – Latin America Hormone Replacement Therapy Market

Key countries in Latin America such as Brazil and Mexico are assessed. Demand for hormone replacement therapy across these countries is analyzed and sales of various hormone replacement therapy products in the region are sketched in the chapter.

Chapter 13 – Europe Hormone Replacement Therapy Market

European business outlook apropos to hormone replacement therapy market along with country wise assessment is provided in this chapter. Countries such as Germany, United Kingdom, France, Spain, Russia and Italy are included wherein individual hormone replacement therapy market analysis is carried out across these geographies.

Chapter 14 – Asia Pacific Excluding Japan (APEJ) Hormone Replacement Therapy Market

This extensive chapter in the hormone replacement therapy market report includes assessment of adoption and use of hormone replacement therapy across countries such as India, China, Australia and rest of APEJ. Value share analysis of hormone replacement therapy market and lucrativeness of APEJ in the hormone replacement therapy marketplace is highlighted in the chapter.

Chapter 15 – Japan Hormone Replacement Therapy Market

Segmental snapshot of hormone replacement therapy market across the country is provided in this chapter. In addition, business outlook in Japan in the hormone replacement therapy space along with key aspects influencing growth are covered in the chapter.

Chapter 16 – Middle East and Africa (MEA) Hormone Replacement Therapy Market

Business outlook of hormone replacement therapy market across Africa, GCC countries, and rest of MEA is provided in the report. Various aspects impacting the growth of MEA hormone replacement therapy market are also included here. Overall attractiveness of MEA hormone replacement therapy market is provided that can be used as an indicator from investment standpoint.

Chapter 17 – Competition Landscape

This crucial chapter in the hormone replacement therapy market report provides a competitive dashboard, industry structure and market shares of companies and includes profiles of key participants in the hormone replacement therapy market. 

Chapter 18 – Assumptions and Acronyms Used

This chapter in the hormone replacement therapy market report reveals all assumptions taken into consideration while drafting the report. For instance, all values being represented in US$ Mn and CAGR in percentage. It also includes various acronyms used in the report throughout. 

Chapter 19 – Research Methodology

The chapter in the hormone replacement therapy market report reveals the methodology adopted for gleaning key insights on hormone replacement therapy market. Data from primary, secondary and external sources such as SEC filings, company press releases, newspapers, company annual reports, and literature from regulatory authorities such as WHO and NHI is gathered and triangulated to obtain highly realistic and accurate hormone replacement therapy statistics.  

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. FACT.MR Analysis and Recommendations
     1.4. Wheel of FortuneTM – Opportunity Analysis

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy
     2.3. Scope of Research

3. Market Dynamics
     3.1. Drivers
     3.2. Restraints
     3.3. Opportunity
     3.4. Trends

4. Associate industry Dynamics
     4.1. Key Regulations
     4.2. Political-Economical-Social-Technological-Environment (PESTE) Analysis
     4.3. Average Selling Prices (US$), By each Country

5. Key Inclusion
     5.1. Patient Journey in HRT
     5.2. Physician’s Treatment Preference (Physician Survey’s)
     5.3. Top 5 Prescribed Brands, By each Country

6. Global Hormone replacement therapy Market Analysis and Forecast
     6.1. Global Hormone replacement therapy Market Outlook
            6.1.1. Market Value (US$ Mn) Forecast and Analysis
            6.1.2. Regional Demand Assessment
     6.2. Market Value Share by Region

7. Global Hormone Replacement Therapy Market Analysis and Forecast, By Therapy Type
     7.1. Introduction
            7.1.1. Market Share Analysis By Therapy Type
            7.1.2. Y-o-Y Growth Projections By Therapy type
     7.2. Market Size Analysis By Therapy Type
            7.2.1. Estrogen Replacement Therapy
            7.2.2. Thyroid Hormone Replacement Therapy
            7.2.3. Growth Hormone Replacement Therapy
     7.3. Market Attractiveness Analysis By Therapy Type

8. Global Hormone replacement therapy Market Analysis and Forecast, By Dosage form Type
     8.1. Introduction
            8.1.1. Market Share Analysis By Dosage form Type
            8.1.2. Y-o-Y Growth Projections By Dosage form Type
     8.2. Market Size Analysis By Dosage form Type
            8.2.1. Tablets/ Capsules
            8.2.2. Patches
            8.2.3. Injection
            8.2.4. Implants
            8.2.5. Creams or Gels Market Attractiveness Analysis By Dosage form Type

9. Global Hormone replacement therapy Market Analysis and Forecast, By Disease indications
     9.1. Introduction
            9.1.1. Market Share Analysis By Disease indications
            9.1.2. Y-o-Y Growth Projections By Disease indications
     9.2. Market Size Analysis By Disease indications
            9.2.1. Menopause
            9.2.2. Osteoporosis
            9.2.3. Thyroid
            9.2.4. Growth Hormone Deficiency
     9.3. Market Attractiveness Analysis By Disease Indications

10. Global Hormone replacement therapy Market Analysis and Forecast, By Distribution Channel
     10.1.Introduction
            10.1.1. Market Share Analysis By Distribution Channel
            10.1.2. Y-o-Y Growth Projections By Distribution Channel
     10.2.Market Size Analysis By Distribution Channel
            10.2.1. Hospital Pharmacies
            10.2.2. Retail Pharmacies
            10.2.3. Clinics
            10.2.4. Online Pharmacies

11. North America Hormone Replacement Therapy Market Analysis
     11.1. Introduction
            11.1.1. North America Business Outlook
            11.1.2. North America Hormone Replacement Therapy Market Outlook
     11.2. North America Hormone Replacement Therapy Market Outlook
            11.2.1. Market Value (US$ Mn) Forecast and Analysis
            11.2.2. Country Wise Demand Assessment
                     11.2.2.1. US Market Value Share
                     11.2.2.2. Canada Market Value Share
     11.3. North America Hormone Replacement Therapy Market Analysis by Therapy Type
            11.3.1. Value(US$ Mn) Forecast by Therapy Type
            11.3.2. Y-o-Y Growth Comparison by Therapy Type
     11.4. North America Hormone Replacement Therapy Market Analysis by dosage form Type
            11.4.1. Value(US$ Mn) Forecast by dosage Form Type
            11.4.2. Y-o-Y Growth Comparison by dosage form Type
     11.5. North America Hormone Replacement Therapy Market Analysis by Disease Indication
            11.5.1. Value(US$ Mn) Forecast by Disease Indication
            11.5.2. Y-o-Y Growth Comparison by Disease Indication
     11.6. North America Hormone Replacement Therapy Market Analysis by Distribution Channel
            11.6.1. Value(US$ Mn) Forecast by Distribution Channel
            11.6.2. Y-o-Y Growth Comparison by Distribution Channel
     11.7. Market Attractiveness Analysis
     11.8. List of Key Market Participants By Country
     11.9. Market Trends

12. Latin America Hormone Replacement Therapy Market Analysis
     12.1. Introduction
            12.1.1. Latin America Business Outlook
            12.1.2. Latin America Hormone Replacement Therapy Market Outlook
     12.2. Latin America Hormone Replacement Therapy Market Outlook
            12.2.1. Market Value (US$ Mn) Forecast and Analysis
            12.2.2. Country Wise Demand Assessment
                     12.2.2.1. Brazil
                     12.2.2.2. Mexico
                     12.2.2.3. Rest of LA
     12.3. Latin America Hormone Replacement Therapy Market Analysis by Therapy Type
            12.3.1. Value(US$ Mn) Forecast by Therapy Type
            12.3.2. Y-o-Y Growth Comparison by Therapy Type
     12.4. Latin America Hormone Replacement Therapy Market Analysis by dosage form Type
            12.4.1. Value(US$ Mn) Forecast by dosage Form Type
            12.4.2. Y-o-Y Growth Comparison by dosage form Type
     12.5. Latin America Hormone Replacement Therapy Market Analysis by Disease Indication
            12.5.1. Value(US$ Mn) Forecast by Disease Indication
            12.5.2. Y-o-Y Growth Comparison by Disease Indication
     12.6. Latin America Hormone Replacement Therapy Market Analysis by Distribution Channel
            12.6.1. Value(US$ Mn) Forecast by Distribution Channel
            12.6.2. Y-o-Y Growth Comparison by Distribution Channel
     12.7. Market Attractiveness Analysis
     12.8. List of Key Market Participants By Country
     12.9. Market Trends

13. Europe Hormone Replacement Therapy Market Analysis
     13.1. Introduction
            13.1.1. Europe Business Outlook
            13.1.2. Europe Hormone Replacement Therapy Market Outlook
     13.2. Europe Hormone Replacement Therapy Market Outlook
            13.2.1. Market Value (US$ Mn) Forecast and Analysis
            13.2.2. Country Wise Demand Assessment
                     13.2.2.1. UK
                     13.2.2.2. France
                     13.2.2.3. Germany
                     13.2.2.4. Italy
                     13.2.2.5. Spain
                     13.2.2.6. Russia
                     13.2.2.7. Rest of EU
     13.3. Europe Hormone Replacement Therapy Market Analysis by Therapy Type
            13.3.1. Value(US$ Mn) Forecast by Therapy Type
            13.3.2. Y-o-Y Growth Comparison by Therapy Type
     13.4. Europe Hormone Replacement Therapy Market Analysis by dosage form Type
            13.4.1. Value(US$ Mn) Forecast by dosage Form Type
            13.4.2. Y-o-Y Growth Comparison by dosage form Type
     13.5. Europe Hormone Replacement Therapy Market Analysis by Disease Indication
            13.5.1. Value(US$ Mn) Forecast by Disease Indication
            13.5.2. Y-o-Y Growth Comparison by Disease Indication
     13.6. Europe Hormone Replacement Therapy Market Analysis by Distribution Channel
            13.6.1. Value(US$ Mn) Forecast by Distribution Channel
            13.6.2. Y-o-Y Growth Comparison by Distribution Channel
     13.7. Market Attractiveness Analysis
     13.8. List of Key Market Participants By Country
     13.9. Market Trends

14. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis
     14.1. Introduction
            14.1.1. Asia Pacific ex. Japan Business Outlook
            14.1.2. Asia Pacific ex. Japan Hormone Replacement Therapy Market Outlook
     14.2. Asia Pacific ex. Japan Hormone Replacement Therapy Market Outlook
            14.2.1. Market Value (US$ Mn) Forecast and Analysis
            14.2.2. Country Wise Demand Assessment
                     14.2.2.1. India
                     14.2.2.2. China
                     14.2.2.3. Australia
                     14.2.2.4. Rest of APEJ
     14.3. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by Therapy Type
            14.3.1. Value(US$ Mn) Forecast by Therapy Type
            14.3.2. Y-o-Y Growth Comparison by Therapy Type
     14.4. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by dosage form Type
            14.4.1. Value(US$ Mn) Forecast by dosage Form Type
            14.4.2. Y-o-Y Growth Comparison by dosage form Type
     14.5. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by Disease Indication
            14.5.1. Value(US$ Mn) Forecast by Disease Indication
            14.5.2. Y-o-Y Growth Comparison by Disease Indication
     14.6. Asia Pacific ex. Japan Hormone Replacement Therapy Market Analysis by Distribution Channel
            14.6.1. Value(US$ Mn) Forecast by Distribution Channel
            14.6.2. Y-o-Y Growth Comparison by Distribution Channel
     14.7. Market Attractiveness Analysis
     14.8. List of Key Market Participants By Country
     14.9. Market Trends

15. Japan Hormone Replacement Therapy Market Analysis
     15.1. Introduction
            15.1.1. Japan Business Outlook
            15.1.2. Japan Hormone Replacement Therapy Market Outlook
     15.2. Japan Hormone Replacement Therapy Market Outlook
            15.2.1. Market Value (US$ Mn) Forecast and Analysis
     15.3. Japan Hormone Replacement Therapy Market Analysis by Therapy Type
            15.3.1. Value(US$ Mn) Forecast by Therapy Type
            15.3.2. Y-o-Y Growth Comparison by Therapy Type
     15.4. Japan Hormone Replacement Therapy Market Analysis by dosage form Type
            15.4.1. Value(US$ Mn) Forecast by dosage Form Type
            15.4.2. Y-o-Y Growth Comparison by dosage form Type
     15.5. Japan Hormone Replacement Therapy Market Analysis by Disease Indication
            15.5.1. Value(US$ Mn) Forecast by Disease Indication
            15.5.2. Y-o-Y Growth Comparison by Disease Indication
     15.6. Japan Hormone Replacement Therapy Market Analysis by Distribution Channel
            15.6.1. Value(US$ Mn) Forecast by Distribution Channel
            15.6.2. Y-o-Y Growth Comparison by Distribution Channel
     15.7. Market Attractiveness Analysis
     15.8. List of Key Market Participants By Country
     15.9. Market Trends

16. MEA Hormone Replacement Therapy Market Analysis
     16.1. Introduction
            16.1.1. MEA Business Outlook
            16.1.2. MEA Hormone Replacement Therapy Market Outlook
     16.2. MEA Hormone Replacement Therapy Market Outlook
            16.2.1. Market Value (US$ Mn) Forecast and Analysis
            16.2.2. Country Wise Demand Assessment
                     16.2.2.1. Africa
                     16.2.2.2. GCC Countries
                     16.2.2.3. Rest of MEA
     16.3. MEA Hormone Replacement Therapy Market Analysis by Therapy Type
            16.3.1. Value(US$ Mn) Forecast by Therapy Type
            16.3.2. Y-o-Y Growth Comparison by Therapy Type
     16.4. MEA Hormone Replacement Therapy Market Analysis by dosage form Type
            16.4.1. Value(US$ Mn) Forecast by dosage Form Type
            16.4.2. Y-o-Y Growth Comparison by dosage form Type
     16.5. MEA Hormone Replacement Therapy Market Analysis by Disease Indication
            16.5.1. Value(US$ Mn) Forecast by Disease Indication
            16.5.2. Y-o-Y Growth Comparison by Disease Indication
     16.6. MEA Hormone Replacement Therapy Market Analysis by Distribution Channel
            16.6.1. Value(US$ Mn) Forecast by Distribution Channel
            16.6.2. Y-o-Y Growth Comparison by Distribution Channel
     16.7. Market Attractiveness Analysis
     16.8. List of Key Market Participants By Country
     16.9. Market Trends

17. Competition Landscape
     17.1.Competition Dashboard
     17.2.Industry Structure and Company Market Share
     17.3.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
     17.4.Key Players
            17.4.1. AbbVie, Inc.
            17.4.2. Allergan plc
            17.4.3. Bayer AG
            17.4.4. Eli Lilly and Company
            17.4.5. Endo Pharmaceuticals, Inc.
            17.4.6. F. Hoffmann-La Roche Ltd.
            17.4.7. Merck KGaA
            17.4.8. Mylan N.V.
            17.4.9. Novartis AG
            17.4.10. Novo Nordisk A/S
            17.4.11. Pfizer, Inc.
            17.4.12. Others

18. Assumptions and Acronyms Used

19. Research Methodology
     19.1. Detailed information on the process used to collect information and data for compiling this report

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Hormone Replacement Therapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028